Researchers at UCLA Health have shown that boosting the activity of a healthy gene copy can offset the effects of a mutation linked to autism. The approach, using a modified form of CRISPR, targets enhancers to control gene expression, offering a new direction for treating autism and related neurodevelopmental conditions.
Scientists identify chimeric RNA molecules as essential in cellular health and disease, finding they play a wide variety of critical roles in vital cellular processes. Faulty chimeric RNA are often malfunctioning in breast cancer tumors, prompting new cancer treatments targeting specific chimeras.
Researchers have created the most detailed cellular atlas of the basal ganglia, a region critical for movement, habit formation, and emotion. The atlas, developed by a global consortium of over 50 institutions, provides a comprehensive library of brain cell types and datasets across human, macaque, marmoset, and mouse species.
A new study reveals that the CASS4 gene plays a crucial role in Alzheimer's disease by directing brain-cleaning immune cells, which can be disrupted leading to the buildup of toxic plaques. This discovery offers new hope for the development of treatments or prevention strategies by targeting the gene or microglia in the brain.
Researchers propose that unstable repeat DNA may contribute to the missing heritability of schizophrenia and bipolar disorder, suggesting a link to glutamine variation. The proposed mechanism involves glutamine dysregulation in astrocytes, which can lead to psychosis.
The HuBMAP Data Portal offers a rich resource for deepening understanding of human health and disease, with 9,000 datasets from 500 donors. Researchers can explore and analyze complex relationships between trillions of cells using the portal's tools and visualization capabilities.
Researchers at Stanford University have developed a non-invasive gene editing technique using ultrasound and light-emitting nanoparticles, enabling precise control over gene editing in specific locations of the brain and body. This breakthrough could lead to new treatments for neuropathic pain and other conditions, offering a more targ...
A new study reveals that premature birth fundamentally alters brain development, disrupting cerebellar growth and neural connections. The findings suggest that premature birth's lasting effects on neurodevelopment are rooted in altered cellular and molecular mechanisms, potentially impacting later motor and cognitive outcomes.
Researchers mapped 5 million individual immune cells from 2,000 people, identifying nearly 1,500 genes linked to a range of diseases. The findings provide a detailed map of how genetic variation shapes the immune system, enabling targeted treatments and precision medicine.
African genomes show nearly a million more genetic variants than non-African genomes, holding the key to precision medicine and global health equity. Research into African genomics could develop treatments for inherited diseases and improve diagnoses.
Researchers developed an aging-specific screening platform that identified SRSF1 as a gene with multifaceted rejuvenation potential, reducing hallmarks of aging and extending lifespan in mice by 14%. The study provides a promising avenue for devising clinically useful de-aging strategies.
Researchers at Aarhus University have demonstrated a new form of gene therapy that can correct genetic defects in patients' own stem cells. The technique, called prime editing, builds on CRISPR technology but works in a different way, inserting a small piece of correct DNA at the precise location of the defect. This method has signific...
Researchers found that people with a higher genetic risk for Alzheimer’s who volunteered or helped others showed slower cognitive decline. The study, which analyzed 22 years of data, found that even modest amounts of helping others provided significant cognitive benefits.
Rosalind Franklin created 'Photo 51' after using an earlier image, 'Photo 49', to calculate key features of DNA's helical structure. The new research reveals that Franklin carefully planned and produced the high-quality repeat of the earlier image, challenging the long-held belief that she did not recognize its significance.
A new study found that people with the sickle cell variant are infected by a distinct variety of malaria parasites, which may contribute to their lower disease rates. The parasite strain is present in asymptomatic infections, differing between those with and without the sickle cell variant.
The current reference genome, GRCh38, has limitations that can lead to false positives and false negatives in disease susceptibility testing. A new graph-based pan-genome graph is proposed to address these limitations, providing a more comprehensive picture of human genetic diversity.
The Novo Nordisk Foundation has renewed its $53 million commitment to the Broad Institute's Center for Genomic Mechanisms of Disease. This funding will accelerate research into the genetic and biological mechanisms underlying type 2 diabetes and obesity, with the goal of identifying new therapeutic targets. The center will expand on it...
A study found that a common lupus-associated genetic variant strengthens antiviral immune responses while increasing the risk of autoimmunity. This genetic variant affects the IRF7 transcription factor, which plays a central role in the antiviral immune response.
Researchers have identified two new genes associated with primary ciliary dyskinesia (PCD), a rare disease affecting respiratory and other systems. The discovery provides a new diagnostic tool and potential targets for treatment, improving understanding of cilia function and disease progression.
Researchers found that chemotherapy drugs like cisplatin and carboplatin can leave characteristic mutations in healthy liver tissue of children, potentially increasing the risk of future cancers. The study used advanced sequencing technology to detect mutations in non-cancerous tissues from pediatric cancer patients.
Researchers have developed the AlphaGenome Atlas, a comprehensive map of more than 9 billion possible single-letter DNA changes. The one-petabyte dataset provides artificial intelligence-generated predictions for the molecular effects of these changes, accelerating understanding of the human genome.
An eight-year study of 335 women reveals individual molecular trajectories of aging diverge from population-wide patterns, influenced by genetics and environmental exposures. The study found over 5,000 genes and 181 metabolites changed over time, including those associated with age-related diseases.
The AI BioDesign accelerator will generate open models, datasets, and tools to create new biological solutions for human health and environmental challenges. The goal is to learn and model the rules biology uses to build life, enabling the development of new drugs, enzymes, and biological computers.
Researchers found that meal timing programs the liver's daily rhythms and can have serious metabolic and health consequences when out of sync. The liver uses food signals to activate metabolic pathways, which can conflict with the body's natural circadian clock, leading to health issues.
Consuelo Walss-Bass's family was affected by schizophrenia, yet her sister was spared. Her laboratory addresses the genetic gap by exploring signaling alterations in neurons derived from affected sibling pairs, identifying convergent abnormalities in PI3K/GSK3 signaling.
A new research tool, PGS-TRI, analyzes family data to understand how genetics and environment contribute to autism risk. The tool provides a more precise look at how 'nature' and 'nurture' interact within families, allowing researchers to better understand the complex factors that shape a child's health.
Researchers from USC-led study found that different epigenetic clocks capture distinct aspects of cellular aging, while introducing new gene-expression based clocks with stronger predictive power. These tools can better predict age-related disease and mortality by examining DNA methylation patterns and gene expression.
A new review highlights how molecular biology advances are reframing PAH as a complex vascular remodeling disease driven by endothelial dysfunction, chronic inflammation, metabolic dysregulation, and genetic susceptibility. Emerging therapies target the BMP/TGF-β pathway, growth factor signaling, and inflammatory pathways.
Ancient human genomes showed differing functional PSPH gene variants, with modern-day phosphoserine phosphatase having the greatest function. The study highlights potential in combining evolution-guided variant prioritization for uncovering functional differences.
Researchers developed a new method to study long-distance DNA regulation in rare immune cells, uncovering previously hidden connections relevant to autoimmune diseases. The approach prioritized over 100 candidate genes linked to Crohn's disease risk, including CLN3, which was not typically associated with the condition.
A new computational approach, TRACE, reveals a more complex picture of human evolution by detecting ancient hominin ancestry in modern humans. The approach recovers known Neanderthal and Denisovan ancestry while uncovering previously unknown episodes of interbreeding with archaic human groups.
A study at USC discovers a common genetic variant in Indigenous American populations that silences the microprotein MENTSH, restoring it improves insulin signaling and blocks diet-induced weight gain. MENTSH-based therapies could offer a precision-medicine approach to Type 2 diabetes.
A Mount Sinai study found that single-cell atlases, used for mapping the human body and training AI models, may not accurately represent global populations. The analysis of over 13,500 samples revealed an overrepresentation of European ancestry and underrepresentation of Asian and Latino individuals, highlighting the need for diverse a...
Researchers have identified a widespread source of error in a popular genome study method and created a machine-learning tool to correct it. PATTY uses machine learning to reduce artifacts while preserving real signals in noisy data, giving researchers a clearer view of gene activity control.
A new atlas has been developed to map the potential of genes in predicting adverse drug reactions, utilizing a comprehensive analysis of genetic data from the Million Veteran Program. This genomic-led strategy aims to anticipate drug safety effects by identifying key genetic variants associated with adverse reactions.
Researchers developed an advanced generative model called ALADYNOULLI to uncover underlying disease processes and predict individual outcomes. The model reduced complex patient histories into 21 reproducible 'latent' disease signatures, which were highly similar across datasets and reproduced known disease processes.
A new study from MUSC suggests that combining flexible testing options and community partnerships can bring populationwide genomic screening to rural and socially vulnerable communities. Over 50,000 adults have completed screening through In Our DNA SC, a program that has reached participants in all 46 South Carolina counties.
A recent study published in Obesity Reviews found that knowledge about genetic risk alone is not sufficient to change behavior and reduce excess weight. Long-term, personalised support is crucial for effective behavioural change.
Research found that Parkinson's disease triggers shared 'stress responses' but also differs between men and women at the cellular level, particularly in how glial cells manage energy and protect nerve connections. This discovery may lead to more personalized treatments for patients.
Researchers discovered how ATRX mutations reprogram gene regulation architecture to fuel glioma growth and progression. Targeting genes downstream of ATRX slowed cancer progression in preclinical models.
Researchers discover that kidney cancer cells lacking the tumor suppressor gene SETD2 become highly dependent on protein BCL-xL for survival. By targeting this dependency, they can selectively eliminate SETD2-deficient cancer cells, offering a potential new therapeutic strategy for patients with aggressive subset of kidney cancers.
Scientists have identified a unique chimeric RNA called UBA1-CDK16 that plays important roles in women's blood cell development and disease severity. The findings suggest the chimeric RNA may serve as a natural brake to protect women from excessive autoimmune activity.
Researchers developed a groundbreaking approach to prioritize schizophrenia-associated genes by analyzing genetic data from over 102,000 individuals. This study uncovered 641 previously unrecognized genes associated with schizophrenia, shedding light on the complex interactions between distant genetic variants.
A team studied 173 multiplex families from the Azores and Madeira islands, finding a single broken gene that travels through three generations and causes different illnesses. The CHD2 mutation is rare and affects schizophrenia, mood disorder, and autism in different family members.
The University of Bath has recruited leading psychiatric geneticist Professor Laura Huckins to lead mental health research, focusing on eating disorders and PTSD. She aims to provide answers and treatments for vulnerable populations, combining genetic data and human brain studies to predict individual responses to their environment.
Researchers at ISTA and Norwegian Institute of Public Health found that environmental factors influenced by parents' genes can significantly impact children's traits like height, body weight, and school performance. The study used genetic and phenotypic data from over 30,000 families to separate direct and indirect genetic effects.
Researchers discover repetitive regions of the human genome, previously considered 'junk DNA', could contribute to cancer development through epigenetic and transcriptional alterations. The study uses advanced sequencing technologies to characterize these regions and their molecular interactions.
A large Japanese study found that maintaining a healthier profile with lower lifestyle and health risks can significantly lower dementia risk in people with one or no APOE ε4 alleles. However, individuals carrying two APOE ε4 alleles may require different preventive or therapeutic approaches.
Researchers create detailed cell map to identify genetic and cellular drivers of IBD, finding that many genetic effects occur in immune cells and epithelial cells. The study demonstrates the power of single-cell sequencing and genetics to unlock disease mysteries.
A new AI tool, HERRO, corrects errors in nanopore sequencing reads to produce high-quality complete genome assemblies. This innovation enables researchers to build more accurate and complete genome maps with a simpler workflow, unlocking potential for precision medicine advancements.
A new study from the University of Exeter found that genetic testing can identify the cause of pancreatic agenesis in 98 per cent of cases. This diagnosis allows healthcare professionals to provide families with a better understanding of the condition's impacts, risks, and help them find support.
Mount Sinai researchers have uncovered a substantial genetic component to postpartum psychosis, a rare psychiatric illness that occurs after childbirth. The study found rare damaging mutations in the HMGCR gene and significant genetic overlap with bipolar disorder, schizophrenia, and autoimmune diseases.
A study published in Nature suggests that individuals at the extremes of certain traits, such as cholesterol and blood glucose, are more likely to have rare genetic variants with larger effects. This discovery may lead to better preventive care and treatments for those with extreme trait values.
A study published in Nature Communications identified over 50 previously unknown genes that affect lipid composition in the human body. These findings may provide a better understanding of aging processes and pathological conditions such as Alzheimer's disease, diabetes, and cardiovascular dysfunctions.
Recent advancements in animal models, organoid models, and bioengineered organoids have provided new tools for studying primary sclerosing cholangitis. These models replicate the effects of bile retention and inflammation, enabling studies of disease mechanisms, drug screening, and preclinical evaluation.
Researchers have developed a new gene editing technology called 'prime assembly' that allows efficient insertion of large DNA segments into the human genome. This innovation enables treatment of genetic diseases by replacing entire genes, promising substantial progress in treating conditions with multiple mutations.
A study published in Chinese Neurosurgical Journal reports KRAS gene overexpression associated with brain arteriovenous malformation (bAVM) pathogenesis. The research found altered gene expression profiles linked to cell adhesion, signaling, and mitochondrial function, suggesting KRAS-driven molecular alterations play a role in bAVM de...
The APOE2 gene variant is associated with exceptional longevity and reduced Alzheimer's risk. Research reveals that APOE2 helps human neurons maintain genomic integrity and resist cellular senescence, driving neurodegeneration. This study offers a mechanistic answer to the protective mechanism behind APOE2's role in aging.
The alliance aims to address the diagnostic gap in rare diseases, leveraging genomics, AI, and technology. BGI Genomics is establishing a national-level rare disease diagnosis center with improved access across Southeast Asia.
Researchers developed RegVelo, an AI framework that models cellular dynamics and gene regulation to predict cellular fate decisions. The model traces developmental trajectories and simulates regulatory interactions, providing insights into hidden drivers of development and potential therapeutic targets.